(Q29617899)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15789122

30 April 2017

1 reference

Wang D

1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15789122

30 April 2017

Lippard SJ

series ordinal

2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15789122

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15789122

30 April 2017

language of work or name

1 reference

30 April 2017

publication date

April 2005

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15789122

Nature Reviews Drug Discovery

30 April 2017

published in

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15789122

30 April 2017

volume

4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15789122

30 April 2017

page(s)

307-20

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15789122

30 April 2017

issue

4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15789122

Evidence for involvement of HMGB1 protein in human DNA mismatch repair

30 April 2017

cites work

1 reference

Interaction with p53 enhances binding of cisplatin-modified DNA by high mobility group 1 protein

1 May 2017

1 reference

The HMG-domain protein Ixr1 blocks excision repair of cisplatin-DNA adducts in yeast

1 May 2017

1 reference

Association of chromatin proteins high mobility group box (HMGB) 1 and HMGB2 with mitotic chromosomes

1 May 2017

1 reference

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

1 May 2017

1 reference

The chromatin-specific transcription elongation factor FACT comprises human SPT16 and SSRP1 proteins

1 May 2017

1 reference

Interaction of FACT, SSRP1, and the high mobility group (HMG) domain of SSRP1 with DNA damaged by the anticancer drug cisplatin

1 May 2017

1 reference

Cellular survival: a play in three Akts

1 May 2017

1 reference

Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1

1 May 2017

1 reference

c-Abl: activation and nuclear targets

1 May 2017

1 reference

c-Abl-induced apoptosis, but not cell cycle arrest, requires mitogen-activated protein kinase kinase 6 activation

1 May 2017

1 reference

The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage

1 May 2017

1 reference

Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis

1 May 2017

1 reference

p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage

1 May 2017

1 reference

p53 modulation of TFIIH-associated nucleotide excision repair activity

1 May 2017

1 reference

MSK2 and MSK1 mediate the mitogen- and stress-induced phosphorylation of histone H3 and HMG-14

1 May 2017

1 reference

The nucleosomal response associated with immediate-early gene induction is mediated via alternative MAP kinase cascades: MSK1 as a potential histone H3/HMG-14 kinase

1 May 2017

1 reference

Signal transduction by the JNK group of MAP kinases

1 May 2017

1 reference

Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216

1 May 2017

1 reference

Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25

1 May 2017

1 reference

Essential role of BETA2/NeuroD1 in development of the vestibular and auditory systems

1 May 2017

1 reference

Linkage of ATM to cell cycle regulation by the Chk2 protein kinase

1 May 2017

1 reference

Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro

1 May 2017

1 reference

Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair

1 May 2017

1 reference

Msh2 status modulates both apoptosis and mutation frequency in the murine small intestine

1 May 2017

1 reference

Msh-2 suppresses in vivo mutation in a gene dose and lesion dependent manner

1 May 2017

1 reference

Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade

1 May 2017

1 reference

Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization

1 May 2017

1 reference

Selective removal of transcription-blocking DNA damage from the transcribed strand of the mammalian DHFR gene

1 May 2017

1 reference

Structure, Recognition, and Processing of Cisplatin-DNA Adducts.

1 May 2017

1 reference

Current status of platinum-based antitumor drugs

31 March 2020

1 reference

Platinum-based chemotherapy in metastatic breast cancer: current status.

31 March 2020

1 reference

Meeting report on 8th International Symposium on Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy

31 March 2020

1 reference

Biochemical modulation of Cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance

31 March 2020

1 reference

Recognition and processing of cisplatin- and oxaliplatin-DNA adducts

31 March 2020

1 reference

Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel

31 March 2020

1 reference

Platinum-based anticancer agents: innovative design strategies and biological perspectives.

31 March 2020

1 reference

Current status of the development of trans-platinum antitumor drugs

31 March 2020

1 reference

Synthesis, characterization, and cytotoxicity of a series of estrogen-tethered platinum(IV) complexes

31 March 2020

1 reference

Decreased cisplatin uptake by resistant L1210 leukemia cells

31 March 2020

1 reference

Modulation ofcis-diamminedichloroplatinum(II) accumulation and sensitivity by forskolin and 3-isobutyl-1-methylxanthine in sensitive and resistant human ovarian carcinoma cells

31 March 2020

1 reference

Kinetics and mechanism of uptake of platinum-based pharmaceuticals by the rat small intestine

31 March 2020

1 reference

Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals

31 March 2020

1 reference

The copper influx transporter human copper transport protein 1 regulates the uptake of cisplatin in human ovarian carcinoma cells

31 March 2020

1 reference

Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) as a chemoresistance marker in human oral squamous cell carcinoma treated with cisplatin

31 March 2020

1 reference

Prognostic value of the Cu-transporting ATPase in ovarian carcinoma patients receiving cisplatin-based chemotherapy.

31 March 2020

1 reference

Copper-transporting P-type adenosine triphosphatase (ATP7B) as a cisplatin based chemoresistance marker in ovarian carcinoma: comparative analysis with expression of MDR1, MRP1, MRP2, LRP and BCRP.

31 March 2020

1 reference

Copper-transporting P-type adenosine triphosphatase (ATP7B) is expressed in human gastric carcinoma.

31 March 2020

1 reference

Copper(II) protects yeast against the toxicity of cisplatin independently of the induction of metallothionein and the inhibition of platinum uptake

31 March 2020

1 reference

Cross-resistance to cisplatin in cells with acquired resistance to copper

31 March 2020

1 reference

Preclinical studies identifying carboplatin as a viable cisplatin alternative

31 March 2020

1 reference

Antitumor activity of a new platinum complex, oxalato (trans-l-1,2-diaminocyclohexane)platinum (II): new experimental data

31 March 2020

1 reference

Protein interactions with platinum-DNA adducts: from structure to function

31 March 2020

1 reference

Multiple States of Stalled T7 RNA Polymerase at DNA Lesions Generated by Platinum Anticancer Agents

31 March 2020

1 reference

Effect of DNA polymerases and high mobility group protein 1 on the carrier ligand specificity for translesion synthesis past platinum-DNA adducts

31 March 2020

1 reference

MutS preferentially recognizes cisplatin- over oxaliplatin-modified DNA.

31 March 2020

1 reference

Recognition of cisplatin adducts by cellular proteins

31 March 2020

1 reference

Fine structure and activity of discrete RAG-HMG complexes on V(D)J recombination signals

31 March 2020

1 reference

The RAG1 homeodomain recruits HMG1 and HMG2 to facilitate recombination signal sequence binding and to enhance the intrinsic DNA-bending activity of RAG1-RAG2

31 March 2020

1 reference

Stimulation of V(D)J cleavage by high mobility group proteins

31 March 2020

1 reference

High mobility group protein-1 (HMG-1) is a unique activator of p53

31 March 2020

1 reference

HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease

31 March 2020

1 reference

Repair of cisplatin--DNA adducts by the mammalian excision nuclease

31 March 2020

1 reference

Testis-specific HMG-domain protein alters the responses of cells to cisplatin

31 March 2020

1 reference

Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin

31 March 2020

1 reference

Ixr1, a yeast protein that binds to platinated DNA and confers sensitivity to cisplatin.

31 March 2020

1 reference

Cisplatin sensitivity in Hmbg1-/- and Hmbg1+/+ mouse cells

31 March 2020

1 reference

Mutagenesis of the HMGB (high-mobility group B) protein Cmb1 (cytosine-mismatch binding 1) of Schizosaccharomyces pombe: effects on recognition of DNA mismatches and damage

31 March 2020

1 reference

The DNA chaperone HMGB1 facilitates ACF/CHRAC-dependent nucleosome sliding

31 March 2020

1 reference

The nuclear protein HMGB1, a new kind of chemokine?

31 March 2020

1 reference

31 March 2020

Chromatin and cell death

1 reference

Isolation and characterization of human cDNA clones encoding a high mobility group box protein that recognizes structural distortions to DNA caused by binding of the anticancer agent cisplatin

31 March 2020

1 reference

Tracking FACT and the RNA polymerase II elongation complex through chromatin in vivo

31 March 2020

1 reference

The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase

31 March 2020

1 reference

Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks

31 March 2020

1 reference

Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP).

31 March 2020

1 reference

Negative regulation of mixed lineage kinase 3 by protein kinase B/AKT leads to cell survival

31 March 2020

1 reference

Modulation of PI3K/Akt pathway by E1a mediates sensitivity to cisplatin.

31 March 2020

1 reference

Inhibition of NFkappaB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models

31 March 2020

1 reference

c-Abl tyrosine kinase can mediate tumor cell apoptosis independently of the Rb and p53 tumor suppressors.

31 March 2020

1 reference

Requirement of caspase-mediated cleavage of c-Abl during stress-induced apoptosis

31 March 2020

1 reference

Regulation of cell death by the Abl tyrosine kinase

31 March 2020

1 reference

c-Abl neutralizes the inhibitory effect of Mdm2 on p53.

31 March 2020

1 reference

Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents

31 March 2020

1 reference

Determination of cell fate by c-Abl activation in the response to DNA damage

31 March 2020

1 reference

Regulation of p73 by c-Abl through the p38 MAP kinase pathway.

31 March 2020

1 reference

Activation of MEK kinase 1 by the c-Abl protein tyrosine kinase in response to DNA damage

31 March 2020

1 reference

Activation of p38 mitogen-activated protein kinase by c-Abl-dependent and -independent mechanisms

31 March 2020

1 reference

The DNA-binding domain of human c-Abl tyrosine kinase promotes the interaction of a HMG chromosomal protein with DNA.

31 March 2020

1 reference

Leukoregulin induction of prostaglandin-endoperoxide H synthase-2 in human orbital fibroblasts. An in vitro model for connective tissue inflammation

31 March 2020

1 reference

p53 mutations in human cancers

31 March 2020

1 reference

Decision making by p53: life, death and cancer

31 March 2020

1 reference

DNA repair is activated in early stages of p53-induced apoptosis

31 March 2020

1 reference

p53-dependent pathways of apoptosis

31 March 2020

1 reference

Potential roles for p53 in nucleotide excision repair.

31 March 2020

1 reference

Implication of p53 in base excision DNA repair: in vivo evidence

31 March 2020

1 reference

p53 and regulation of DNA damage recognition during nucleotide excision repair

31 March 2020

1 reference

p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene

31 March 2020

1 reference

Cisplatin-induced post-translational modification of histones H3 and H4.

31 March 2020

1 reference

Inhibition of DNA replication factor RPA by p53.

31 March 2020

1 reference

Molecular determinants of the cytotoxicity of platinum compounds: the contribution of in silico research

31 March 2020

1 reference

A newly developed adenovirus-mediated transfer of a wild-type p53 gene increases sensitivity to cis-diamminedichloroplatinum (II) in p53-deleted ovarian cancer cells

31 March 2020

1 reference

Effect of p53 gene transfer and cisplatin in a peritonitis carcinomatosa model with p53-deficient ovarian cancer cells

31 March 2020

1 reference

Effect of p53 status on sensitivity to platinum complexes in a human ovarian cancer cell line.

31 March 2020

1 reference

Modulation of cisplatinum cytotoxicity by p53: effect of p53-mediated apoptosis and DNA repair

31 March 2020

1 reference

p53-Dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells

31 March 2020

1 reference

Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53.

31 March 2020

1 reference

Modulation of p53 and p73 levels by cyclin G: implication of a negative feedback regulation

31 March 2020

1 reference

The negative role of cyclin G in ATM-dependent p53 activation

31 March 2020

1 reference

BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair.

31 March 2020

1 reference

p38 MAP kinase: a convergence point in cancer therapy

31 March 2020

1 reference

Mitogen-activated protein kinases in apoptosis regulation

31 March 2020

1 reference

Role of the p38 MAPK pathway in cisplatin-based therapy

31 March 2020

1 reference

p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases

31 March 2020

1 reference

Cisplatin and UV radiation induce activation of the stress-activated protein kinase p38gamma in human melanoma cells

31 March 2020

1 reference

Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells

31 March 2020

1 reference

Transcriptional regulation by the MAP kinase signaling cascades

31 March 2020

1 reference

Requirement for ERK activation in cisplatin-induced apoptosis

31 March 2020

1 reference

Effect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatin

31 March 2020

1 reference

Cisplatin induces a persistent activation of JNK that is related to cell death

31 March 2020

1 reference

Inhibition of extracellular signal-regulated protein kinase or c-Jun N-terminal protein kinase cascade, differentially activated by cisplatin, sensitizes human ovarian cancer cell line

31 March 2020

1 reference

The MEK1 inhibitor PD98059 sensitizes C8161 melanoma cells to cisplatin-induced apoptosis

31 March 2020

1 reference

Increase of the resistance of human cervical carcinoma cells to cisplatin by inhibition of the MEK to ERK signaling pathway partly via enhancement of anticancer drug-induced NF kappa B activation

31 March 2020

1 reference

The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat

31 March 2020

1 reference

Lack of c-Jun activity increases survival to cisplatin

31 March 2020

1 reference

Regulation of platinum-compound cytotoxicity by the c-Jun N-terminal kinase and c-Jun signaling pathway in small-cell lung cancer cells

31 March 2020

1 reference

The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin.

31 March 2020

1 reference

The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation

31 March 2020

1 reference

CL100/MKP-1 modulates JNK activation and apoptosis in response to cisplatin

31 March 2020

1 reference

Conditional expression of mitogen-activated protein kinase phosphatase-1, MKP-1, is cytoprotective against UV-induced apoptosis

31 March 2020

1 reference

DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis

31 March 2020

1 reference

Activation of the p53-dependent G1 checkpoint response in mouse embryo fibroblasts depends on the specific DNA damage inducer

31 March 2020

1 reference

Cdc25 Mitotic Inducer Targeted by Chk1 DNA Damage Checkpoint Kinase

31 March 2020

1 reference

Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein

31 March 2020

1 reference

The eukaryotic nucleotide excision repair pathway

31 March 2020

1 reference

DNA repair in an active gene: removal of pyrimidine dimers from the DHFR gene of CHO cells is much more efficient than in the genome overall.

31 March 2020

1 reference

Ultraviolet-sensitive syndrome cells are defective in transcription-coupled repair of cyclobutane pyrimidine dimers

31 March 2020

1 reference

Subpathways of nucleotide excision repair and their regulation

31 March 2020

1 reference

Nucleotide excision repair from site-specifically platinum-modified nucleosomes.

31 March 2020

1 reference

Nucleotide-excision repair of DNA in cell-free extracts of the yeast Saccharomyces cerevisiae

31 March 2020

1 reference

Reduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell lines.

31 March 2020

1 reference

Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours

31 March 2020

1 reference

Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance

31 March 2020

1 reference

Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair

31 March 2020

1 reference

BRCA1 transcriptionally regulates damaged DNA binding protein (DDB2) in the DNA repair response following UV-irradiation.

31 March 2020

1 reference

p53-mediated DNA repair responses to UV radiation: studies of mouse cells lacking p53, p21, and/or gadd45 genes

31 March 2020

1 reference

Functional interactions and signaling properties of mammalian DNA mismatch repair proteins

31 March 2020

1 reference

Involvement of the DNA mismatch repair system in antineoplastic drug resistance

31 March 2020

1 reference

A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer

31 March 2020

1 reference

Cisplatin and adriamycin resistance are associated with MutLalpha and mismatch repair deficiency in an ovarian tumor cell line

31 March 2020

1 reference

Loss of DNA mismatch repair: effects on the rate of mutation to drug resistance

31 March 2020

1 reference

Msh2 deficiency does not contribute to cisplatin resistance in mouse embryonic stem cells

31 March 2020

1 reference

Spontaneous development of drug resistance: mismatch repair and p53 defects in resistance to cisplatin in human tumor cells

31 March 2020

1 reference

DNA mismatch repair and acquired cisplatin resistance in E. coli and human ovarian carcinoma cells

31 March 2020

1 reference

Is cisplatin-induced cell death always produced by apoptosis?

31 March 2020

1 reference

Pharmacological Modulation of Poly(ADP-ribose) Polymerase-Mediated Cell Death: Exploitation in Cancer Chemotherapy

31 March 2020

1 reference

Functions of poly(ADP-ribose) polymerase (PARP) in DNA repair, genomic integrity and cell death

31 March 2020

1 reference

Chemosensitivity of solid tumor cellsin vitro is related to activation of the CD95 system

31 March 2020

1 reference

Abrogation of mitochondrial cytochrome c release and caspase-3 activation in acquired multidrug resistance.

31 March 2020

1 reference

Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma

31 March 2020

1 reference

Cisplatin-induced renal cell apoptosis: caspase 3-dependent and -independent pathways

31 March 2020

1 reference

The interaction of cisplatin and analogues with DNA in reconstituted chromatin

31 March 2020

1 reference

cis- and trans-diamminedichloroplatinum(II) interstrand cross-linking of a defined sequence nucleosomal core particle.

31 March 2020

1 reference

Interaction of cis-diamminedichloroplatinum (II) to chromatin. Specificity of the drug distribution

31 March 2020

1 reference

Binding of cis - and trans -dichlorodiammineplatinum(II) to the nucleosome core

31 March 2020

1 reference

In vivo effects of cis- and trans-diamminedichloroplatinum(II) on SV40 chromosomes: differential repair, DNA-protein cross-linking, and inhibition of replication

31 March 2020

1 reference

cis-Diamminedichloroplatinum (II) modified chromatin and nucleosomal core particle probed with DNase I

31 March 2020

1 reference

Cisplatin inhibits chromatin remodeling, transcription factor binding, and transcription from the mouse mammary tumor virus promoter in vivo

31 March 2020

1 reference

High-throughput synthesis and screening of platinum drug candidates

31 March 2020

1 reference

Carboxylation of Kinetically Inert Platinum(IV) Hydroxy Complexes. An Entr.acte.ee into Orally Active Platinum(IV) Antitumor Agents

31 March 2020

1 reference

Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model

31 March 2020

1 reference

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

31 March 2020

1 reference

Estrogen-derived steroidal metal complexes: agents for cellular delivery of metal centers to estrogen receptor-positive cells.

31 March 2020

1 reference

Treatment of advanced non-small-cell lung cancer with two-drug combinations

31 March 2020

1 reference

Platinum compounds in the treatment of advanced breast cancer

31 March 2020

1 reference

Cisplatin and its analogues in the treatment of advanced breast cancer: a review

31 March 2020

1 reference

Platinum drugs in the treatment of non-small-cell lung cancer

31 March 2020

1 reference

Treatment of testicular germ-cell cancer: a cochrane evidence-based systematic review

31 March 2020

1 reference

Clinical development of platinum complexes in cancer therapy: an historical perspective and an update.

31 March 2020

1 reference

The chemotherapy of head and neck cancer.

31 March 2020

1 reference

Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells

31 March 2020

1 reference

Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo

31 March 2020

1 reference

The cellular interaction of 5-fluorouracil and cisplatin in a human colon carcinoma cell line

31 March 2020

1 reference

Effect of DNA conformation on cisplatin adduct formation

31 March 2020

1 reference

Cross-linking of glutathione to DNA by cancer chemotherapeutic platinum coordination complexes

31 March 2020

1 reference

Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion.

31 March 2020

1 reference

Effect of glutathione on DNA repair in cisplatin-resistant human ovarian cancer cell lines.

31 March 2020

1 reference

Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy

31 March 2020

1 reference

Enhanced DNA repair and resistance to cisplatin in human ovarian cancer

31 March 2020

1 reference

At the crossroads of necrosis and apoptosis: signaling to multiple cellular targets by HMGB1.

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

cis-diamminedichloroplatinum (II) modified chromatin and nucleosomal core particle

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15789122

30 April 2017

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

151679

1044896419

0 references

151679

1 reference

Consolidated OpenCitations Corpus – April 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15789122

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017